NCOR1 may be a potential biomarker of a novel molecular subtype of prostate cancer

Prostate cancer (PCa) is the most frequently diagnosed male cancer. An earlier study of a cohort of 333 primary prostate carcinomas showed that 74% of these tumors fell into one of seven subtypes of a molecular taxonomy defined by specific gene fusions (ERG, ETV1/4 and FLI1) or mutations (SPOP, FOXA...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Lu, Zhang, Lixia, Liu, Lei, Dong, Liping, Dong, Yuan, Zhu, Wenhe, Wang, Huiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714081/
https://www.ncbi.nlm.nih.gov/pubmed/33058520
http://dx.doi.org/10.1002/2211-5463.13004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714081/
https://www.ncbi.nlm.nih.gov/pubmed/33058520
http://dx.doi.org/10.1002/2211-5463.13004

Ejemplares similares